The CDC's decision came just months after the U.S. Food and Drug Administration forced Pfizer to slap a damning warning on its Comirnaty vaccine noting the estimated unadjusted incidence of heart conditions following administration of the 2023-2024 formula of the shot, as well as the longitudinal results of a 2024 study concerning cardiac manifestations and outcomes of vaccine-associated myocarditis in American youths.
No comments:
Post a Comment